Sprycel (dasatinib), a new oral drug for certain forms of leukemia
There's lots of excitement about Sprycel (dasatinib), a new oral drug for certain forms of leukemia.
It's for patients who are resistant to or can't take other treatments...including Gleevec (imatinib).
Sprycel is a tyrosine kinase inhibitor...similar to Gleevec.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote